Cancer Control Journal Vol 3, No 1, CME Pretest

This Journal provides 4 hours of Category I Continuing Medical Education

Complimentary CME Credits

Physicans can earn up to 4 credit hours of Category I for the Physican's Recognition Award of the American Medical Association by reading the material in this issue and successfully answering the questions on the posttest at the end of this issue. Complete instructions are given on the posttest pages. Every successfully answered 10 questions will earn 1 credit hour. CME is presented by an unrestricted educational grant from Bristol-Myers Oncology Division.

Educational Objectives

After reading this issue, clinicians will be expected to:

• Recognize the relevance of genetic counseling in the management of hereditary nonopolyposis colorectal cancer
• Know the value and impact of screening for colorectal cancer
• Be aware of approaches to avoid colostomy and to manage metastasis
• Understand the role of radioimmunoguided surgery in staging and therapy approaches
• Be familiar with the management and control of vancomycin resistant enterococci

Pretest

1. What proportion of patients with colorectal cancer in the United States is related to hereditary nonpolyposis colorectal cancer?

a. 1% to 5%

b. 10% to 15%

c. 20% to 30%

d. over 50%

2. What is the likelihood that a person in a screening program who has a positive fecal occult blood test has colon or rectal cancer?

a. 0.5% to 1%

b. 3% to 5%

c. 10% to 15%

d. 30% to 40%

3. Which of the following characteristics of a primary rectal cancer is associated with a low risk of lymph node metastases or local recurrence?

a. larger than 3cm in diameter

b. well-differentiated histology

c. ulceration of the tumor

d. tumor fixed to rectal wall

---

---